Blog
Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics
Vertex (VERX) reported $196.65 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 11.1%. EPS of $0.17 for the same period compares to $0.15 a year ago.
Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Privia Health (PRVA) reported $603.85 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 25.8%. EPS of $0.02 for the same period compares to $0.03 a year
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
Charles River Laboratories (CRL) reported $995.83 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 1.2%. EPS of $2.06 for the same period compares to
Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Xeris Biopharma (XERS) reported $83.13 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 38.3%. EPS of $0.01 for the same period compares to -$0.06 a
Compared to Estimates, Planet Fitness (PLNT) Q1 Earnings: A Look at Key Metrics
Planet Fitness (PLNT) reported $337.24 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 21.9%. EPS of $0.74 for the same period compares to $0.59 a year
Here's What Key Metrics Tell Us About Playtika (PLTK) Q1 Earnings
Playtika Holding (PLTK) reported $744.7 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 5.5%. EPS of $0.04 for the same period compares to $0.09 a year
Compared to Estimates, Bentley Systems (BSY) Q1 Earnings: A Look at Key Metrics
For the quarter ended March 2026, Bentley Systems, Incorporated (BSY) reported revenue of $424.18 million, up 14.5% over the same period last year. EPS came in at $0.38, compared to $0.35 in the
Compared to Estimates, Maximus (MMS) Q2 Earnings: A Look at Key Metrics
For the quarter ended March 2026, Maximus (MMS) reported revenue of $1.31 billion, down 4.1% over the same period last year. EPS came in at $2.07, compared to $2.01 in the year-ago quarter.
The
Here's What Key Metrics Tell Us About Clear Channel Outdoor (CCO) Q1 Earnings
For the quarter ended March 2026, Clear Channel Outdoor (CCO) reported revenue of $373.86 million, up 11.9% over the same period last year. EPS came in at -$0.10, compared to -$0.11 in the year-ago
Compared to Estimates, MKS (MKSI) Q1 Earnings: A Look at Key Metrics
MKS (MKSI) reported $1.08 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 15.2%. EPS of $2.30 for the same period compares to $1.71 a year ago.
The
MarketAxess (MKTX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, MarketAxess (MKTX) reported revenue of $233.38 million, up 11.9% over the same period last year. EPS came in at $2.25, compared to $1.87 in the year-ago quarter.
Shift4 Payments (FOUR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2026, Shift4 Payments (FOUR) reported revenue of $549 million, up 49% over the same period last year. EPS came in at $0.97, compared to $1.07 in the year-ago quarter.
The
Wall Street Analysts See Teekay Tankers (TNK) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
For the quarter ended March 2026, Evolent Health (EVH) reported revenue of $496.25 million, up 2.6% over the same period last year. EPS came in at -$0.02, compared to $0.06 in the year-ago quarter.
Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, Collegium Pharmaceutical (COLL) reported revenue of $193.52 million, up 8.9% over the same period last year. EPS came in at $1.76, compared to $1.49 in the year-ago
Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Avient (AVNT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Avient (AVNT) reported $847.4 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 2.5%. EPS of $0.83 for the same period compares to $0.76 a year ago.
The
Is Cipher Digital Inc. (CIFR) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
BlackSky Technology (BKSY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
BlackSky Technology Inc. (BKSY) reported $20.77 million in revenue for the quarter ended March 2026, representing a year-over-year decline of 29.7%. EPS of -$0.82 for the same period compares to
SentinelOne (S) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 Earnings
Viatris (VTRS) reported $3.52 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 8.1%. EPS of $0.59 for the same period compares to $0.50 a year ago.
The
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Compared to Estimates, Adient (ADNT) Q2 Earnings: A Look at Key Metrics
For the quarter ended March 2026, Adient (ADNT) reported revenue of $3.87 billion, up 7% over the same period last year. EPS came in at $0.52, compared to $0.69 in the year-ago quarter.
The reported
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Veracyte (VCYT) Crossed Above the 200-Day Moving Average: What That Means for Investors
After reaching an important support level, Veracyte (VCYT) could be a good stock pick from a technical perspective. VCYT surpassed resistance at the 200-day moving average, suggesting a long-term


